Actively Recruiting
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
Led by AdventHealth · Updated on 2026-01-05
342
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
Sponsors
A
AdventHealth
Lead Sponsor
N
Northwestern University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
CONDITIONS
Official Title
Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Ability to provide informed consent
- Scheduled for colonoscopy to evaluate and remove colon polyps
- Non-pedunculated polyps measuring 20 mm or larger
You will not qualify if you...
- Pedunculated polyps
- Inflammatory bowel disease
- Unable to provide informed consent
- Lesions smaller than 20 mm
- Lesions involving the lips of the ileocecal valve, appendiceal orifice, or fully circumferential lesions
- Any standard contraindication to anesthesia or colonoscopy, including pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AdventHealth
Orlando, Florida, United States, 32804
Actively Recruiting
Research Team
D
Diana Paredes, RN
CONTACT
P
Petronio Martins, MHA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here